+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention



Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention



Clinica Chimica Acta; International Journal of Clinical Chemistry 451(Pt A): 71-77



Severe infections represent the main cause of neonatal mortality accounting for more than one million neonatal deaths worldwide every year. Antibiotics are the most commonly prescribed medications in neonatal intensive care units. The benefits of antibiotic therapy when indicated are clearly enormous, but the continued and widespread use of antibiotics has generated over the years a strong selective pressure on microorganisms, favoring the emergence of resistant strains. Health agencies worldwide are galvanizing attention toward antibiotic resistance in gram-positive and gram-negative bacteria. Infections in neonatal units due to multidrug and extensively multidrug resistant bacteria are rising and are already seriously challenging antibiotic treatment options. While there is a growing choice of agents against multi-resistant gram-positive bacteria, new options for multi-resistant gram-negative bacteria in the clinical practice have decreased significantly in the last 20 years making the treatment of infections caused by multidrug-resistant pathogens challenging mostly in neonates. Treatment options are currently limited and will be some years before any new treatment for neonates become available for clinical use, if ever. The aim of the review is to highlight the current knowledge on antibiotic resistance in the neonatal population, the possible therapeutic choices, and the prevention strategies to adopt in order to reduce the emergency and spread of resistant strains.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058386608

Download citation: RISBibTeXText

PMID: 25749408

DOI: 10.1016/j.cca.2015.02.038


Related references

Adenovirus: current epidemiology and emerging approaches to prevention and treatment. Current Infectious Disease Reports 16(8): 416, 2014

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opinion on PharmacoTherapy 15(10): 1351-1370, 2014

The current and emerging therapeutic approaches in drug-resistant epilepsy management. Acta Neurologica Belgica 119(2): 155-162, 2019

Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. Journal of ChemoTherapy 29(Sup1): 19-28, 2017

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 11(2): 97-107, 2004

Neonatal infections caused by Streptococcus group B--their epidemiology, clinical picture, diagnosis, treatment and prevention. Akusherstvo i Ginekologiia 33(3): 39-40, 1994

Molecular epidemiology of community-acquired oxacillin-resistant Staphylococcus aureus from the emerging infections and the epidemiology of Iowa organisms study. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 40: 69, 2000

New therapeutic approaches in the prevention and treatment of recurrent infections of the lower urinary tract. Minerva Urologica 29(5): 235-240, 1977

Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clinic Proceedings 80(9): 1201-7; Quiz 1208, 2005

Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland. International Urology and Nephrology 51(2): 335-341, 2019

Current and Future Approaches to the Prevention and Treatment of Staphylococcal Medical Device-Related Infections. Current Pharmaceutical Design 21(1): 100-113, 2014

Current and future approaches to the prevention and treatment of staphylococcal medical device-related infections. Current Pharmaceutical Design 21(1): 100-113, 2015

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease. Gut and Liver 2019:, 2019

Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. Journal of Clinical Microbiology 41(7): 3001-3006, 2003

Gay men: current challenges and emerging approaches in HIV prevention. New South Wales Public Health Bulletin 21(3-4): 65-68, 2010